Evoke Pharma, Inc. Gains 132.24%
Tue, Nov 04, 2025 at 07:11 PM
Evoke Pharma, Inc. (EVOK:NASDAQ) jumped higher at $10.66, representing a gain of 132.2%. On Tue, Nov 04, 2025, EVOK:NASDAQ touched a New 2-Week High of $10.66. The stock got featured on our News Catalysts scanner on Tue, Nov 04, 2025 at 11:01 AM in the 'INVESTOR UPDATE' category. From Tue, Oct 21, 2025, the stock recorded 60.00% Up Days and 54.55% Green Days
About Evoke Pharma, Inc. (EVOK:NASDAQ)
Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.
Top 10 Gainers:
- Evoke Pharma, Inc. (EVOK:NASDAQ), 132.24%
- Davis Commodities Limited (DTCK:NASDAQ), 63.46%
- Cambium Networks Corporation (CMBM:NASDAQ), 58.82%
- PTL Limited (PTLE:NASDAQ), 51.53%
- Denny's Corporation (DENN:NASDAQ), 50.37%
- Tactile Systems Technology, Inc. (TCMD:NASDAQ), 40.65%
- Hertz Global Holdings, Inc. (HTZ:NASDAQ), 36.23%
- Captivision Inc. (CAPT:NASDAQ), 31.77%
- Xometry, Inc. (XMTR:NASDAQ), 28.93%
- Kforce Inc. (KFRC:NYSE), 28.69%